Explore our materials

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Drug-Drug Interactions: considerations | Anca Streinu-Cercel, MD, PhD

Cihan Yurdaydin

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Update of new drugs | Cihan Yurdaydin, MD

Pavel Khaykin

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

IVDU | Pavel Khaykin, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

(Abstract) The prevalence of HBV, HCV and HIV infection in Romania - a nationwide screening program for surveillance of viral infections | O. Sandulescu

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

(Abstract) The effect of lamivudine- versus tenofovir-containing antiretroviral regimen on hepatitis B infection in a cohort of HIV infected long term survivors | A. Temereanca

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Prospects for Cure | Patrick Kennedy

Cihan Yurdaydin

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

State-of-the-art treatment of Hepatitis B | Cihan Yurdaydin, MD

Vadim Rassokhin

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Local situation in Russia | Vadim Rassokhin, MD

Central and Eastern European Meeting on Viral Hepatitis and HIV 2016

Local situation in Turkey | Serhat Unal, MD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

Oral microbiota in relation to HIV infection and oral infection in perinatally HIV-infected adolescents | Bruce Paster, PhD

International Workshop on Microbiome in HIV Pathogenesis, Prevention and Treatment 2016

The Human Microbiome and Cancer: New Opportunities For Population Studies | Emily Vogtmann, PhD, MPH